481 In vitro and vivo evaluation of the pan FGFR inhibitor ARQ 087 and selective pan AKT inhibitor ARQ 092 in endometrial cancer: potential for combination therapy

Autor: Meade, J., Wick, M.J., Vaught, T., Chavez, R., Rundle, M., Stanfield, K., Quattrochi, B., Papadopoulos, K.P., Dransfield, D.T., Yu, Y., Marchlik, E., Chiesa, E., Tolcher, A.W.
Zdroj: In European Journal of Cancer November 2014 50 Supplement 6:156-157
Databáze: ScienceDirect